Velpatasvir

Name: Velpatasvir

Dosing & Uses

Hepatitis C

Not available as a single agent in the United States

See combination drug monographs for

  • Sofosbuvir/velpatasvir
  • Sofosbuvir/velpatasvir/voxilaprevir

Safety and efficacy not established

Pharmacology

Pharmacology

Velpatasvir: Pangenotypic HCV NS5A inhibitor; the NS5A protein is required for viral replication

Patient Handout

Print without Office InfoPrint with Office Info
(web3)